LISATA THERAP.INC.DL-001 Net Asset Quality Index
LISATA THERAP.INC.DL-001 net asset quality index. LISATA THERAP.INC.DL-001 (8NE) has a Net Asset Quality Index of 72.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €11.03 Million minus total liabilities of €3.04 Million yields net assets of €7.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of LISATA THERAP.INC.DL-001 for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of LISATA THERAP.INC.DL-001 (2021–2025)
Net asset quality index of LISATA THERAP.INC.DL-001 from 2021 to 2025. This chart shows how LISATA THERAP.INC.DL-001's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at 72.5%, representing net assets of €7.99 Million against total assets of €11.03 Million EUR. Check 8NE goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
LISATA THERAP.INC.DL-001 Net Asset Quality Index by Year (2021–2025)
LISATA THERAP.INC.DL-001 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for LISATA THERAP.INC.DL-001 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 8NE stock market capitalisation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 82.3% | €14.60 Million | €17.74 Million | €3.14 Million | ▼ -1.5 pp |
| 2024 | 83.8% | €29.32 Million | €35.00 Million | €5.68 Million | ▼ -3.8 pp |
| 2023 | 87.6% | €47.89 Million | €54.69 Million | €6.80 Million | ▼ -3.2 pp |
| 2022 | 90.8% | €66.32 Million | €73.03 Million | €6.71 Million | ▼ -4.0 pp |
| 2021 | 94.8% | €92.00 Million | €97.01 Million | €5.01 Million | — |